Vystar Corp (VYST)

[turn144]

A 1% market share in the US replacement market would yield sales of over 350k units annually - @$1K/unit that is $350M in annual Revenue - 1% - that's it.

I am sure 1% is achievable - even in this crowded market. But let's say 1/2% - that still is $175M.

Focusing on Vytex product advantage is required - hence the spin out of a piece Rx Air. You could see the similar strategy for FEC.

We shall see, but all the tough work is being wrapped up - now they can focus on strategy and growth. Cash (for Investment in growth) is an issue - will have to see how that is addressed.

Good luck to all still holding.